For now, mTORC3 contains ETV7 and other undefined components [99], while mTORC4 includes mEAK7 and DNA-PKcs, which are hypothesized to play roles in tumorigenesis and anti-cancer drug resistance by controlling T cell’s response to DNA damage and cancer cell physiology [97,102,103]. Here, PRKDC is linked to cancer.